Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): New aspects in hematopoiesis

Platelets

Volumn 10, Issue 1, 1999, Pages 5-16

  Murate, T ^a   Hayakawa, T ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROID POTENTIATING FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE;

BONE MARROW CELL; CELL GROWTH; CHEMICAL STRUCTURE; ERYTHROLEUKEMIA CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HEMATOPOIESIS; HUMAN; HUMAN CELL; MEGAKARYOBLAST; PRIORITY JOURNAL; REVIEW; STROMA CELL;

EID: 0032967881     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109976293     Document Type: Review

References (94)

1. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250.
2. Woessner JF Jr. Matrix metalloproteins and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-54.
3. Shingleton WD, Hodges DJ, Brick P, Cawston TE. Collagenase: a key enzyme in collagen turnover. Biochem Cell Biol 1996; 74: 759-75.
4. Nagase H. Matrix metalloproteinases. In NM Hooper, ed. Zinc Metalloproteinases in Health and Disease. London: Talor and Francis, 1996; 153-204.
5. Hayakawa T. Matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in the development and disease of oral tissues. Dent Japan 1998; 34: 167-77.
6. Denhart D, Feng B, Edwards DR, Cocuzzi ET, Malyanker UM. Tissue inhibitors of metalloproteinases (TIMP aka EPA): structure, control of expression and biological functions. Pharmac Ther 1993; 59: 329-41.
7. Hayakawa T. Tissue inhibitors of metalloproteinases and their cell growth-promoting activity. Cell Struct Func 1994; 19: 109-14.
8. Edwards DR, Beaudry PP, Laing TD, Kowal V, Leco KJ, Leco PA et al. The roles of tissue inhibitors of metalloproteinases in tissue remodeling and cell growth. 1996, Int J Obes 1996; 20(suppl. 3): 9-15.
9. Gomis-Ruth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 1997; 89: 77-81.
10. Howard EW, Bullen EC, Banda MJ. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2. J Biol Chem 1991; 266: 13064-9.
11. Ward R, Hembry RM, Reynolds JJ, Murphy G. The purification of tissue inhibitor of metalloproteinase-2 from its 72 kDa progelatinase complex. Biochem J 1991; 278: 179-87.
12. Nguyen Q, Willenbrock F, Cockett MI, O'Shea M, Docherty AJP, Murphy G. Different domain interactions are involved in the binding of tissue inhibitor of metalloproteinases to stromelysin-1 and gelatinase A. Biochemistry 1994; 33: 2089-95.
13. Apte SS, Olsen BR, Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 1995; 270: 14313-8.
14. Knauper V, Lopes-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 27: 1544-50.
15. Kinoshita T, Sato H, Takino T, Itoh M, Akizawa T, Seiki M. Processing of a precursor of 72-kilo Dalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res 1996; 56: 2535-8.
16. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. J Biol Chem 1996; 271: 17119-23.
17. DeClerck YA, Yean TD, Lu HS, Ting J, Langley KE. Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor M1/TIMP-2. J Biol Chem 1991; 266: 3893-9.
18. Bigg HF, Shi YE, Liu YE, Steffensen B, Overall CM. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelkatinase A. J Biol Chem 1997; 272: 15496-500.
19. Anand-Apte B, Bao L, Smith R, Iwata K, Olsen BR, Zetter B et al. A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumour growth. Biochem Cell Biol 1996; 74: 853-62.
20. Yang B, Yang BL, Savani RC, Turley EA. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44, and link protein. EMBO J 1994; 13: 286-96.
21. Adams JC, Watt EM. Regulation of development and differentiation by the extracellular matrix. Development 1993; 117: 1183-98.
22. Jones PL, Schmidhauser C, Bissell MJ. Regulation of gene expression and cell function by the extracellular matrix. Crit Rev Euk Gene Exp 1993; 3: 37-154.
23. Talhouk RS, Bissell MJ, Werb Z. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial functions during involution. J Cell Biol 1992; 118: 1271-82.
24. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841-8.
25. Lopez-Casillas F, Payne HM, Andres JL, Massague J. Betaglcan presents ligand to the TGF-β signaling receptor. Cell 1993; 73: 1435-44.
26. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 1990; 346: 281-4.
27. Veness-Meehan KA, Cheng ER, Mercier CE, Blixt SL, Johnston CJ, Watkins RH et al. Cell-specific alternations in expression of hypoxia-induced mRNA of lung. Am J Resp Cell Molec Biol 1991; 5: 516-21.
28. Olson JA Jr, Shiverick KT, Ogilvie S, Buhi WC, Raizada MK. Angiotensin II induces secretion of plasminogen activator inhibitor 1 and a tissue metalloproteinase-inhibitor related protein from rat brain astrocytes. Proc Natl Acad Sci USA 1991; 88: 1928-32.
29. Lotz M, Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991; 266: 2017-20.
30. Campbell CE, Flenniken AM, Skup D, Williams BR. Identification of a serum- and phorbol-ester responsive elements in the murine tissue inhibitor of metalloproteinase gene. J Biol Chem 1991; 266: 7199-206.
31. Edwards DR, Rocheleau H, Sharma RR, Willis AJ, Cowie A, Hassell TA et al. Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochem Biophys Acta 1992; 171: 41-55.
32. Declerck YA, Yean TD, Lee Y, Tornich JM, Langley KE. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 1994; 139: 185-91.
33. Nomura S, Hogan BLM, Wills AJ, Heath JK, Edwards DR. Developmental expression of tissue inhibitor of metalloproteinases (TIMP) RNA. Development 1989; 105: 575-83.
34. Waterhouse P, Denhardt DT, Khokha R. Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation. Mol Reprod Dev 1993; 35: 219-26.
35. Apte SS, Hayashi K, Seldin MF, Mattei MG, Hayashi M, Olsen BR. Gene encoding a novel murine TIMP, TIMP-3, is expressed in developing mouse epithelia, cartilage, and muscle and is located on chromosome 10. Develop Dynam 1994; 200: 177-97.
36. Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid potentiating activity. Nature 1985; 318: 66-69.
37. Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ et al. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 1985; 315: 768-71.
38. Westbrook CA, Gasson JC, Gerber SE, Selsted ME, Golde DW. Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity. J Biol Chem 1984; 259: 992-6.
39. Avalos BR, Kaufman SE, Tomonaga M, Williams RE, Golde DW, Gasson JC. K562 cells cells produce and respond to human erythroid potentiating activity. Blood 1988; 71: 1720-5.
40. Hayakawa T, Yamashita K, Kishi J, Harigaya K. Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM102 has erythroid-potentiating activity, suggesting its possibly bifunctional role in the hematopoietic microenvironment. FEBS Lett 1990; 268: 125-8.
41. Stetler-Stevenson WG, Bersch N, Golde DW. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid potentiating activity. FEBS Lett 1992; 296: 231-4.
42. Murate T, Yamashita K, Ohashi H, Kagami Y, Tushita K, Kinoshita T et al. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Exp Hematol 1993; 21: 169-76.
43. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 1991; 97: 670-85.
44. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. FEBS Lett 1992; 298: 29-32.
45. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 1994; 107: 2373-9.
46. Nemeth JA, Goolsby CL. TIMP-2, a growth-stimulating protein from SV-40 transformed human fibroblasts. Exp Cell Res 1993; 207: 376-82.
47. Kolkenbrock H, Orgel D, Hecker-Kia A, Noack W, Ulbrich N. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur J Biochem 1991; 198: 775-81.
48. Corcoran ML, Emmert-Buck MR, McClanahan JL, Pelina-Parker M, Sterler-Stevenson WG. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J Biol Chem 1995; 270: 13453-59.
49. Yamashita K, Suzuki M, Iwata H, Koike T, Hamaguchi M, Shinagawa A et al. Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). FEBS Lett 1996; 396: 103-7.
50. Yamashita K, Suzuki M, Iwata H, Koike T, Hamaguchi M, Shinagawa A et al. Growth signaling through tyrosine and mitogen-activated protein kinases by TIMP-1 and TIMP-2. In Inhibitors of Metallorpoteinases in Development and Diseases (SP Hawkes, DR Edwards, R Khokha) eds. Lausanne, Switzerland: Harwood Academic Publishing, in press, 1998.
51. Yang TT, Hawkes SP. Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10676-80.
52. Kodama S, Yamashita K, Kishi J, Iwata K, Hayakawa T. A sandwich enzyme immunoassay for collagenase inhibitor using monoclonal antibodies. Matrix 1989; 9: 1-6.
53. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin Chim Acta 1993; 220: 31-45.
54. Zhao WQ, Li H, Yamashita K, Guo XK, Hoshino T, Yoshida S et al. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J Cell Sci in press 1998.
55. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993; 157: 351-458.
56. Parkins T. Researches test TIMP-2 as potential tumor terminator. J Natl Canter Inst 1994; 86: 174-5.
57. Satoh H, Kobayashi K, Yamashita S, Kikuchi M, Sendai Y, Hoshi H. Tissue inhibitor of metalloproteinases (TIMP-1) produced by granulosa and oviduct cells enhances in vitro development of bovine embryo. Biol Reprod 1994; 50: 835-44.
58. Vansteenbrugge A, Van Langendonckt A, Massip A, Dessy F. Effect of estrus-associated glycoprotein and tissue inhibitor of metalloproteinase-1 secreted by oviduct cells on in vitro bovine embryo development. Mol Reproduct Develop 1997; 46: 527-34.
59. Boujrad N, Ogwuegbu SO, Garnier M, Lee CH, Martin BM, Papadopoulous V. Identification of a stimulator of steroid synthesis isolated from testis. Science 1995; 268: 1609-12.
60. Nothnick WB, Soloway P, Curry TE Jr. Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene. Biol Reproduct 1997; 56: 1181-8.
61. Matsumoto H, Ishibashi Y, Ohtaki T, Hasegawa Y, Koyama C, Inoue K. Newly established murine pituitary folliculo-stellate-like cell line secretes potent pituitary glandular cell survival factors. Biochem Biophys Res Commun 1993; 194: 909-15.
62. Sharpe-Timms KL, Penney LL, Zimmer RL, Wright JA, Zhang Y, Surewick K. Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with TIMP-1. J Clin Endocrine Metab 1995; 80: 3784-7.
63. Clark IM, Powell LK, Cawston TE. Tissue inhibitor of metalloproteinases (TIMP-1) stimulates the secretion of collagenase from human skin fibroblasts. Biochem Biopys Res Commun 1994; 203: 874-80.
64. Welgus HG, Campbell EJ, Bar-Shavit Z, Senior RM, Teitelbaum SL. Human alveolar macrophages produce a fibroblast like collagenase and collagenase like inhibitor. J Clin Invest 1985; 76: 219-24.
65. Cooksley S, Hipkiss JB, Tickle SP, Holmes-Levers E, Docherty AJ, Murphy G et al. Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complexes. Matrix 1990; 10: 285-91.
66. Clark IM, Powell LK, Wright JK, Cawston TE. Polyclonal and monoclonal antibodies against human tissue inhibitor of metalloproteinases (TIMP) and the design of an enzyme-linked immunosorbent assay to measure TIMP. Matrix 1991; 11: 76-85.
67. Yamashita K, Zhang J, Zou L, Hayakawa H, Noguchi T, Kondo I et al. Dissociation of collagenase-tissue inhibitor of metalloproteinases-1 (TIMP-1) complex - its application for the independent measurements of TIMP- and collagenase activity in culture media and body fluids. Matrix 1992; 12: 481-7.
68. Hayakawa H, Yamashita H, Ohwaki K, Sawa M, Noguchi T, Iwata K et al. Collagenase activity and tissue inhibitor of metalloproteinases-1 (TIMP-1) content in human whole saliva from clinically healthy and periodontally diseased subjects. J Periodont Res 1994; 29: 305-8.
69. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. J Immunol Methods 1990; 127: 103-8.
70. Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinase-1 in sera from patients with rheumatoid arthritis. Arth Rheum 1995; 38: 969-75.
71. Manicourt DH, Fujimoto N, Obata K, Thonar EJ. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases-1 in patients with rheumatoid arthritis. Arth Rheum 1996; 39: 884-6.
72. Muzzillo DA, Imoto M, Fukuda Y, Koyama Y, Saga S, Nagai Y et al. Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases. J Gasroenter Hepatol 1993; 8: 437-41.
73. Ichida T, Miyagiwa M, Inoue K. Diagnostic value of serum laminin, type IV collagen peptides, collagenase inhibitor and prolylhydroxylase on HCC. In, Viral Hepatitis and Hepatocellular Carcinoma, (JL Sung, DS Chen) eds. Hong Kong: Excerpta Medica Asia Ld, 1988; 579-89.
74. Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J. Serum metalloproteinases and their inhibitors; makers for malignant potential. Br J Cancer 1994; 70: 506-12.
75. Cooper TW, Eisen AZ, Stricklin GP, Welgus HG. Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci USA 1985; 82: 2779-83.
76. Murate T, Yamashita K, Isogai C, Suzuki H, Ichihara M, Hatano S et al. The production of tissue inhibitors of Metalloproteinases (TIMPs) in megakaryopoiesis: possible role of, platelet- and megakaryocyte-derived TIMPs in bone marrow fibrosis. Br J Haematol 1997; 99: 181-9.
77. Ross R, Reines E, Bowen-Pope D. Growth factors from platelets, monocytes, and endothelium: their role in cell proliferation. Ann NY Acad Sci 1982; 397: 18-24.
78. Gersuk GM, Carmel R, Pattengale PK. Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders. Blood 1989; 74: 2330-4.
79. Reilly JT. Characterization of an acute micromegakaryocytic leukemia: evidence for the pathogenesis of meylofibrosis. Br J Haematol 1993; 83: 58-62.
80. McCarthy DM. Fibrosis of the bone marrow: content and causes. Br J Haematol 1985; 59: 1-7.
81. Reilly JT. Pathogenesis of idiopathic myelofibrosis. Present status and future directions Br J Haematol 1994; 88: 1-8.
82. Eddy AA, Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein overload proteinuria. Kidney Int 1995; 47: 1546-57.
83. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA. Pathogenesis of interstitial fibrosis in chronic purine amino nucleoside nephrosis. Kid Int 1991; 40: 1020-31.
84. Lafuma C, El-Nobout RA, Crechet F, Hovnanian A, Nartin M. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and TIMP in primary pig skin fibroblast cultures derived from radiation-induced skin. J Invest Dermatol 1994; 102: 945-50.
85. Chesney CM, Harper E, Colman RW. Human platelet collagenase. J Clin Invest 1974; 53: 1647-54.
86. Leven RM, Yee T. Collagenese production by guinea-pig megakaryocytes in vitro. Exp Hematol 1990; 18: 743-7.
87. Robert B, Legrand L, Pignaud G, Caen J, Robert L. Elastinolytic activity associated with blood platelets. Pathol Biol 1969; 17: 615-22.
88. Sawicki G, Sales E, Murat J, Miszta-Lane H, Radomski MW. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616-8.
89. Yamamoto T, Nakamura Y, Nishida J, Emi M, Ogawa M, Mori T et al. Molecular cloning and nucleotide sequence of human pancreatic secretory trypsin inhibitors (PSTI) cDNA. Biochem Biophys Res Commun 1985; 132: 605-12.
90. McKeehan WL, Sakagami Y, Hoshi H, McKeehan KA. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor associated proteinase inhibitors. J Biol Chem 1986; 261: 5378-83.
91. Yavelow J, Caggana M, Beck KA. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors. Cancer Res 1987; 47: 1598-601.
92. Yavelow J, Scott CB, Mayer TC. Fluorescent visualization of binding and internalization of the anti-carcinogenic Bowman-Birk type protease inhibitors in transformed fibroblasts. Cancer Res 1987; 47: 1602-7.
93. Stolow MA, Bauzon DD, Li J, Sedgwick T, Liang VCT, Sang QA et al. Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development. Mol Biol Cell 1996; 71: 1471-83.
94. Llano E, Pendas AM, Knauper V, Sorsa T, Salo T, Salido E et al. Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 1997; 36: 15101-8.